SYNCHRONOUS BILATERAL BREAST CARCINOMA
Clinical trials for SYNCHRONOUS BILATERAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SYNCHRONOUS BILATERAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for SYNCHRONOUS BILATERAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for High-Risk breast cancer patients: can two drugs beat one?
Disease control OngoingThis large study is testing whether adding the drug tucatinib to standard treatment (T-DM1) works better at preventing breast cancer from coming back. It is for people with a specific type of high-risk, HER2-positive breast cancer who still have some cancer cells after their init…
Matched conditions: SYNCHRONOUS BILATERAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 18, 2026 14:42 UTC
-
Major cancer trial questions need for chemo in thousands of women
Disease control OngoingThis large study aimed to find out if adding chemotherapy to standard hormone therapy helps women with a specific type of early-stage breast cancer that has spread to 1-3 lymph nodes. Over 5,000 participants were randomly assigned to receive either hormone therapy alone or hormon…
Matched conditions: SYNCHRONOUS BILATERAL BREAST CARCINOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Feb 25, 2026 15:06 UTC